Gemzar, Cisp, Sunitinib Urothelial Ca
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas E Hutson, DO
US Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology Associates
Tucson, Arizona, United States
- Advanced Medical Specialties
Miami, Florida, United States
- Florida Cancer Institute - New Hope
New Port Richey, Florida, United States
- Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
- Hematology Oncology Associates of Illinois
Chicago, Illinois, United States
- Cancer Care & Hematology Specialists of Chicagoland
Niles, Illinois, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Alliance Hematology Oncology Pa.
Westminster, Maryland, United States
- Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- Arch Medical Services, Inc.
Saint Louiis, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Hematology-Oncology Associates of Northern Nj, Pa
Morristown, New Jersey, United States
- New Mexico Cancer Care Associates
Santa Fe, New Mexico, United States
- New York Oncology Hematology, P.C.
Albany, New York, United States
- Raleigh Hematology Oncology Associates
Raleigh, North Carolina, United States
- Willamette Valley Cancer Center
Springfield, Oregon, United States
- Medical Oncology Associates of Wyoming Valley, Pc
Kingston, Pennsylvania, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Texas Cancer Center - Abilene
Abilene, Texas, United States
- Texas Oncology, P.A. -Amarillo
Amarillo, Texas, United States
- Texas Cancer Center
Arlington, Texas, United States
- Texas Oncology - Round Rock Cancer Center
Austin, Texas, United States
- Mamie Mcfaddin Ward Cancer Center, Texas Oncology
Beaumont, Texas, United States
- Texas Oncology, P.A. - Bedford
Bedford, Texas, United States
- Texas Oncology
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Oncology/methodist Charlton Cancer Ctr.
Dallas, Texas, United States
- Texas Cancer Center
Denton, Texas, United States
- El Paso Cancer Treatment Center - East
El Paso, Texas, United States
- Texas Oncology
Fort Worth, Texas, United States
- Texas Oncology
Garland, Texas, United States
- Longview Cancer Center
Longview, Texas, United States
- South Texas Cancer Center
McAllen, Texas, United States
- Texas Oncology, Pa, Allison Cancer Center
Midland, Texas, United States
- Cancer Care Centers of South Texas
San Antonio, Texas, United States
- Cancer Care Centers of South Texas-Hoast
San Antonio, Texas, United States
- Texas Cancer Center - Sherman
Sherman, Texas, United States
- Texas Oncology Cancer Center - Sugar Land
Sugar Land, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Aug 2012
- Completion
- 31 Aug 2012
- Last update posted
- 25 Oct 2016
- Registered enrollment
- 36
- Registry id
- NCT00821327
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.